Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Microsoft
MSFT
|
+$381M |
| 2 |
Tesla
TSLA
|
+$268M |
| 3 |
Apple
AAPL
|
+$205M |
| 4 |
GE HealthCare
GEHC
|
+$180M |
| 5 |
Exelon
EXC
|
+$123M |
Top Sells
| 1 |
Check Point Software Technologies
CHKP
|
+$187M |
| 2 |
GE Aerospace
GE
|
+$180M |
| 3 |
CyberArk
CYBR
|
+$129M |
| 4 |
Cloudflare
NET
|
+$106M |
| 5 |
BlackBerry
BB
|
+$92.9M |
Sector Composition
| 1 | Technology | 26.4% |
| 2 | Healthcare | 13.8% |
| 3 | Financials | 12.19% |
| 4 | Consumer Discretionary | 9.58% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
TETRA Technologies
TTI
$634M
| $69.2K | ﹤0.01% |
26,118
-1,954,964
| -99% | -$5.18M |
|
|
JBIO
2827
Jade Biosciences, Inc. Common Stock
JBIO
$250M
| $69.2K | ﹤0.01% |
98
+6
| +7% | +$4.24K |
|
2828
Costamare
CMRE
$1.45B
| $68.7K | ﹤0.01% |
7,302
| – | – |
|
2829
Virax Biolabs
VRAX
$2.51M
| $68.4K | ﹤0.01% |
9,976
-285
| -3% | -$1.95K |
|
2830
Cullinan Oncology
CGEM
$392M
| $68K | ﹤0.01% |
6,650
+635
| +11% | +$6.5K |
|
|
SKE
2831
Skeena Resources
SKE
$2.05B
| $67.2K | ﹤0.01% |
10,990
+1,513
| +16% | +$9.26K |
|
|
LUNA
2832
DELISTED
Luna Innovations Incorporated
LUNA
| $67.2K | ﹤0.01% |
9,341
+4,146
| +80% | +$29.8K |
|
2833
Angi Inc
ANGI
$771M
| $67.2K | ﹤0.01% |
2,958
+1,185
| +67% | +$26.9K |
|
2834
Riskified
RSKD
$717M
| $65K | ﹤0.01% |
11,532
+882
| +8% | +$4.97K |
|
|
KLRS
2835
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $64.3K | ﹤0.01% |
710
+28
| +4% | +$2.54K |
|
2836
Monte Rosa Therapeutics
GLUE
$304M
| $64K | ﹤0.01% |
8,219
+781
| +11% | +$6.08K |
|
|
SOHU
2837
Sohu.com
SOHU
$473M
| $63.3K | ﹤0.01% |
4,300
| – | – |
|
2838
Hagerty
HGTY
$1.21B
| $62.8K | ﹤0.01% |
7,184
+971
| +16% | +$8.49K |
|
2839
Innoviz Technologies
INVZ
$353M
| $62.7K | ﹤0.01% |
17,917
| – | – |
|
2840
Esperion Therapeutics
ESPR
$514M
| $62.3K | ﹤0.01% |
39,149
+15,519
| +66% | +$24.7K |
|
2841
Energy Vault
NRGV
$304M
| $62.1K | ﹤0.01% |
29,024
+1,744
| +6% | +$3.73K |
|
2842
Nano X Imaging
NNOX
$247M
| $61.3K | ﹤0.01% |
10,631
| – | – |
|
|
BBUC
2843
Brookfield Business Corp
BBUC
$2.35B
| $61.3K | ﹤0.01% |
3,096
-48
| -2% | -$951 |
|
|
IAUX
2844
i-80 Gold Corp
IAUX
$718M
| $61.2K | ﹤0.01% |
25,194
| – | – |
|
|
FINV
2845
FinVolution Group
FINV
$1.94B
| $61K | ﹤0.01% |
14,625
| – | – |
|
|
LOGC
2846
DELISTED
ContextLogic
LOGC
| $60.3K | ﹤0.01% |
4,510
-12,613
| -74% | -$169K |
|
2847
Compass Therapeutics
CMPX
$601M
| $59.7K | ﹤0.01% |
+18,268
| New | +$59.7K |
|
|
NVTA
2848
DELISTED
Invitae Corporation
NVTA
| $59.6K | ﹤0.01% |
44,326
-48,681
| -52% | -$65.5K |
|
2849
Integral Ad Science
IAS
$1.41B
| $58.3K | ﹤0.01% |
4,094
-116
| -3% | -$1.65K |
|
|
IGMS
2850
DELISTED
IGM Biosciences
IGMS
| $58.2K | ﹤0.01% |
4,238
+190
| +5% | +$2.61K |
|